policy,country,status,explanation,source
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Indonesia,PARTIAL,"Indonesia accepts the ICH CTD format for innovator pharmaceutical product registrations, but compliance with ASEAN technical requirements is mandatory.","https://www.artixio.com/post/indonesia-drug-pharmaceutical-regulations-registration?utm_source=openai,https://www.pharmatutor.org/articles/a-study-of-procedures-for-dossier-preparation-and-their%20marketing-authorisation-in-different-countries-of-selected-drug?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Indonesia,YES,"Indonesia provides a fully digital online submission portal for pharmaceutical product marketing authorization applications through the e-Registration system implemented by the Indonesian Food and Drug Authority (BPOM), accessible at their official website.","https://registrasiobat.pom.go.id/en?utm_source=openai,https://www.linkedin.com/pulse/how-register-imported-products-bpom-2025-cptcorporate-wtfic?utm_source=openai,https://stage.pharma.kalyna.dev/legal-reports/the-pharma-legal-handbook-indonesia/?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Indonesia,YES,"Indonesia legally requires acceptance of another ASEAN Member State's GMP certificate for pharmaceutical manufacturers, as dictated by the ASEAN Sectoral Mutual Recognition Arrangement on GMP, which Indonesia is a signatory to.","https://cil.nus.edu.sg/databasecil/2009-asean-sectoral-mutual-recognition-agreement-on-good-manufacturing-practice-gmp-inspection-of-manufacturers-of-medicinal-products/?utm_source=openai,https://www.pom.go.id/berita/workshop-on-the-development-of-a-mutual-recognition-arrangement-of-bioequivalence-study-reports?utm_source=openai"
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Indonesia,PARTIAL,"Indonesia does not explicitly permit long-term stability data submission at 25°C/60% RH, but it allows accelerated stability studies under these conditions if scientifically justified.",https://www.scribd.com/document/457681671/ASEAN-GUIDELINE-ON-STABILITY-STUDY-OF-DRUG-PRODUCT-docx?utm_source=openai
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Indonesia,YES,Indonesia permits the use of bracketing and matrixing study designs for pharmaceutical product stability testing as recognized by BPOM and directed by the ASEAN Guideline on Stability Study of Drug Products.,"https://farmasiindustri.com/cpob/bracketing-dan-matrixing.html?utm_source=openai,https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai"
Requires halal certification for pharmaceutical products.,Indonesia,YES,"Indonesia requires halal certification for pharmaceutical products as mandated by Act No. 33 of 2014 on Halal Product Assurance, with phased implementation through 2034 (Government Regulation No. 39 of 2021 and Presidential Regulation No. 6 of 2023).","https://halalmui.org/en/ask-the-expert-part-1-from-regulations-to-certification-challenges-of-halal-medicines/?utm_source=openai,https://en.antaranews.com/news/347321/bpjph-highlights-urgency-of-halal-certification-for-health-products?utm_source=openai,https://theleap.id/detail/1915/navigating-the-halal-pharmaceutical-industry-in-indonesia-challenges-and-opportunities?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Indonesia,YES,"In Indonesia, prescription-only pharmaceutical products are required to display a red circle with a black border and the letter 'K', indicating that the medication requires a doctor's prescription (source: Hermina Hospitals).",https://herminahospitals.com/en/news-and-events/kenali-simbol-kode-warna-pada-obat-rs-hermina-pasuruan.html?utm_source=openai
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Indonesia,NO,"Indonesia does not target an average marketing authorization (MA) approval timeline of six months or less, as typical timelines exceed this duration; new drug registrations can take up to 300 working days, while even expedited cases for essential drugs usually take around 100 working days.","https://www.artixio.com/post/indonesia-drug-pharmaceutical-regulations-registration?utm_source=openai,https://baipharm.chemlinked.com/insights/indonesia-drug-registration-pathway?utm_source=openai"
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Indonesia,PARTIAL,"Indonesia has regulations that classify antibiotics as prescription-only and restrict their sale to pharmacies, yet enforcement is lacking as they are often available over-the-counter in pharmacies and kiosks, undermining the effectiveness of the policy ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC2914770/?utm_source=openai), [researchgate.net](https://www.researchgate.net/publication/386849301_Antimicrobial_Policy_in_Indonesia_within_the_One_Health_Context_Literature_Analysis_and_Implementation_Challenges?utm_source=openai)).","https://pmc.ncbi.nlm.nih.gov/articles/PMC2914770/?utm_source=openai,https://www.researchgate.net/publication/386849301_Antimicrobial_Policy_in_Indonesia_within_the_One_Health_Context_Literature_Analysis_and_Implementation_Challenges?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Indonesia,PARTIAL,"Indonesia has initiated steps to establish a national system for antimicrobial resistance (AMR) surveillance and published initial findings, but comprehensive public access to all data may still be limited.","https://www.who.int/indonesia/news/detail/07-07-2023-establishing-national-surveillance-system-for-antimicrobial-consumption-in-indonesia--a-critical-challenge?utm_source=openai,https://www.who.int/indonesia/news/detail/13-02-2025-indonesia-launches-groundbreaking-national-amr-survey-on-bloodstream-infections?utm_source=openai,https://www.thelancet.com/journals/lansea/article/PIIS2772-3682%2822%2900013-0/fulltext?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Vietnam,YES,"Vietnam accepts the ICH CTD format for innovator pharmaceutical product registrations as per Circular No. 44/2014/TT-BYT issued by the Ministry of Health, which allows submissions in this format when ACTD cannot be utilized.","https://vnras.com/the-official-letter-21508-qld-dk-guideline-applying-actd-dossier-ich-ctd-dossier/?utm_source=openai,https://www.productlifegroup.com/specific-regulations-requirements-international-markets/?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Vietnam,YES,"Vietnam provides a fully digital online submission portal for pharmaceutical product marketing authorization applications through the Drug Administration of Vietnam (DAV) at https://dichvucong.dav.gov.vn, which requires applicants to have a registered account and a valid USB Token for digital signing.","https://www.rginsight.com/registration-of-drug-product-in-vietnam-2025?utm_source=openai,https://www.artixio.com/dav-introduces-new-drug-registration-process-in-vietnam/?utm_source=openai,https://medgate.vn/en/dossier-and-procedures-for-obtaining-marketing-authorization-ma-for-ivd-medical-devices-of-class-c-and-d-with-national-technical-regulations/?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Vietnam,PARTIAL,"Vietnam is committed to the ASEAN MRA on GMP, which obligates it to accept GMP certificates from other ASEAN states; however, Decree 163/2025/ND-CP requires that these certificates must be recognized by Vietnam's Ministry of Health, adding conditions to their acceptance.","https://cil.nus.edu.sg/databasecil/2009-asean-sectoral-mutual-recognition-agreement-on-good-manufacturing-practice-gmp-inspection-of-manufacturers-of-medicinal-products/?utm_source=openai,https://gabi-journal.net/a-review-of-international-initiatives-on-pharmaceutical-regulatory-reliance-and-recognition.html?utm_source=openai,https://thuvienphapluat.vn/van-ban/EN/The-thao-Y-te/Decree-163-2025-ND-CP-elaborating-certain-articles-of-the-Law-on-Pharmacy/669216/tieng-anh.aspx?utm_source=openai"
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Vietnam,PARTIAL,"Vietnam permits stability data submission at 25°C/60% RH when justified and accompanied by accelerated studies, although the primary recommendation is 30°C/75% RH according to ASEAN guidelines.",https://www.scribd.com/document/457681671/ASEAN-GUIDELINE-ON-STABILITY-STUDY-OF-DRUG-PRODUCT-docx?utm_source=openai
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Vietnam,YES,"Vietnam permits the use of bracketing and matrixing designs in pharmaceutical stability testing, provided they align with ICH guidelines and are scientifically justified.","https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai,https://1library.net/article/bracketing-matrixing-designs-stability-testing-drug-substances-products.yekpl84y?utm_source=openai,https://aapsopen.springeropen.com/articles/10.1186/s41120-023-00078-5?utm_source=openai"
Requires halal certification for pharmaceutical products.,Vietnam,NO,Vietnam does not require halal certification for pharmaceutical products; it is a voluntary process for companies aiming to access Muslim markets.,"https://halcert.most.gov.vn/en/?utm_source=openai,https://vietnamnews.vn/economy/1689525/local-herbal-company-becomes-halal-certified.html?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Vietnam,NO,"Vietnam's regulations do not mandate the use of a red dot symbol on prescription drugs; instead, the 'Rx' symbol must be used along with specific labeling requirements to indicate prescription status (Circular No. 01/2018/TT-BYT).","https://english.luatvietnam.vn/circular-no-01-2018-tt-byt-dated-january-18-2018-of-the-ministry-of-health-on-labeling-and-package-inserts-of-drugs-and-medicinal-ingredients-158447-doc1.html?utm_source=openai,https://english.luatvietnam.vn/circular-no-06-2016-tt-byt-dated-march-08-2016-of-the-ministry-of-health-on-drug-labeling-103717-doc1.html?utm_source=openai"
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Vietnam,NO,"Vietnam does not target an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products, as the standard approval for new drug registrations typically exceeds twelve months, although there are expedited processes for specific cases.","https://www.scribd.com/document/891750758/12-2025-Tt-Byt-RA-English?utm_source=openai,https://english.luatvietnam.vn/y-te/circular-12-2025-tt-byt-marketing-authorization-of-medicinal-products-400604-d1.html?utm_source=openai,https://hmlf.vn/business-sectors/healthcare/drug-registration-process-vietnam-guide-foreign-companies-2025-2/?utm_source=openai"
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Vietnam,YES,"Vietnam enforces hospital-specific distribution restrictions for certain classes of antimicrobial pharmaceutical products through the establishment of Drug and Therapeutics Committees and Antimicrobial Stewardship teams within hospitals, which manage and regulate antibiotic use.","https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-1158?utm_source=openai,https://aricjournal.biomedcentral.com/articles/10.1186/s13756-024-01364-x?utm_source=openai,https://www.hmplaw.vn/en/restrictions-on-foreign-enterprises-investing-in-the-pharmaceutical-industry-in-vietnam?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Vietnam,PARTIAL,"Vietnam has a national AMR surveillance system, but there is no clear documentation regarding the publication of surveillance data specifically related to pharmaceutical products.","https://www.cdc.gov/globalhealth/healthprotection/fieldupdates/winter-2017/vietnam-tracks-bacteria.html?utm_source=openai,https://www.who.int/vietnam/news/detail/20-11-2023-everyone-has-a-responsibility-to-prevent-antimicrobial-resistance-in-viet-nam?utm_source=openai,https://link.springer.com/article/10.1186/s12982-024-00174-1?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Laos,YES,"Laos accepts the ICH CTD format for innovator pharmaceutical product registrations, alongside its primary use of the ASEAN Common Technical Dossier (ACTD) format, thus allowing flexibility in submission formats.","https://www.productlifegroup.com/introduction-asean-common-technical-dossier-actd-pharmaceutical-registration/?utm_source=openai,https://en.fda.moph.go.th/our-services-new/our-services-pharmaceutical-product-registration-and-approval?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Laos,NO,"As of August 2025, Laos does not offer a fully digital online submission portal for pharmaceutical product marketing authorization applications, requiring applicants to submit physical documents for registration.","https://credevo.com/articles/2021/04/25/generic-drug-approval-process-in-laos/?utm_source=openai,https://globalforum.diaglobal.org/issue/september-2022/digitalization-in-the-asean-pharmaceuticals-market/?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Laos,YES,"Laos is legally required to accept GMP certificates from other ASEAN member states under the ASEAN Mutual Recognition Arrangement (MRA) on GMP Inspection, signed in 2009.","https://globalforum.diaglobal.org/issue/march-2021/harmonization-of-gmp-inspection-and-benefits-to-asean-economic-community/?utm_source=openai,https://en.vietnamplus.vn/asean-imposes-tighter-medicine-and-pharmaceutical-management-post73233.vnp?utm_source=openai"
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Laos,PARTIAL,"While Laos generally recommends stability testing at 30°C/75% RH, the ASEAN guidelines allow for flexibility in testing conditions for products in impermeable containers, potentially permitting stability data at 25°C/60% RH if supported by accelerated studies.","https://pubhtml5.com/otla/smde/basic/?utm_source=openai,https://pharmanotes.org/2022/02/stability-studies-ich-guidelines-q1a-q1f/?utm_source=openai"
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Laos,YES,"Laos permits the use of bracketing and matrixing study designs in pharmaceutical product stability testing according to the ASEAN guidelines, provided specific conditions are met.",https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai
Requires halal certification for pharmaceutical products.,Laos,NO,"As of August 2025, Laos does not require halal certification for pharmaceutical products, though the government is facilitating efforts to improve local manufacturers' compliance with halal standards to enhance export potential.","https://laotiantimes.com/2025/05/14/laos-launches-halal-certification-project-to-boost-exports/?utm_source=openai,https://cert-ease.com/halal-certification-in-laos/?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Laos,NO,There is no evidence that Laos mandates the use of a 'red dot' symbol on prescription-only pharmaceutical products; regulations concerning pharmaceutical labeling do not specify such a requirement (Tilleke & Gibbins).,https://www.tilleke.com/insights/product-labeling-laos-new-regulations-require-local-language-packaging/?utm_source=openai
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Laos,YES,"Laos targets an average marketing authorization approval timeline of six months or less, as the drug registration process typically takes approximately six months once the necessary documents are confirmed.",https://credevo.com/articles/2021/04/25/generic-drug-approval-process-in-laos/?utm_source=openai
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Laos,PARTIAL,"Laos has implemented regulations that restrict the distribution of certain antimicrobial products to hospital settings, but there are ongoing plans to strengthen these controls, particularly regarding prescription-only status, which is not fully in place yet.","https://www.laotradeportal.gov.la/en-gb/site/display/252?utm_source=openai,https://laotiantimes.com/2024/12/04/laos-to-decentralize-medicine-procurement-to-provinces-starting-in-2025/?utm_source=openai,https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065%2820%2930084-5/fulltext?utm_source=openai,https://pubmed.ncbi.nlm.nih.gov/35137095/?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Laos,PARTIAL,"Laos has established a national AMR surveillance system, but comprehensive public access to detailed data regarding antimicrobial resistance and consumption, particularly related to pharmaceutical products, is limited.","https://www.who.int/laos/news/detail/11-07-2018-the-launch-of-the-antimicrobial-resistance-surveillance-program-in-lao-people-s-democratic-republic?utm_source=openai,https://www.who.int/laos/our-work/tracking-and-combating-antimicrobial-resistance?utm_source=openai,https://www.who.int/laos/news/detail/24-11-2022-koica---who-highlight-progress-fighting-antimicrobial-resistance-and-future-opportunities?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Brunei,YES,"Brunei accepts the ICH CTD format for innovator pharmaceutical product registrations, provided that all relevant ASEAN technical requirements are met.","https://www.productlifegroup.com/introduction-asean-common-technical-dossier-actd-pharmaceutical-registration/?utm_source=openai,https://www.scribd.com/document/800284365/International-pharmaceutical-product-registration-2nd-Edition-A-C-Cartwright-all-chapter-instant-download?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Brunei,NO,"Brunei does not provide a fully digital online submission portal for pharmaceutical product marketing authorization applications, as applications must be submitted in person at the Department of Pharmaceutical Services.",https://moh.gov.bn/services/pharmary-services/?utm_source=openai
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Brunei,YES,"Brunei legally requires acceptance of another ASEAN Member State’s GMP certificate for pharmaceutical manufacturers under the ASEAN MRA on GMP Inspection, which mandates mutual recognition of GMP certificates among member states.","https://globalforum.diaglobal.org/issue/september-2018/regulatory-harmonization-and-recognition-continue-in-asean/?utm_source=openai,https://gabi-journal.net/a-review-of-international-initiatives-on-pharmaceutical-regulatory-reliance-and-recognition.html?utm_source=openai,https://en.fda.moph.go.th/international-relation/category/cat-international-cooperation/?utm_source=openai"
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Brunei,PARTIAL,"Brunei may allow stability data submission for pharmaceutical products at 25°C/60% RH if the applicant provides justification, as the ASEAN guidelines permit alternative storage conditions if justified.","https://www.stabilitystudies.in/stability-studies-key-regulatory-guidelines-for-global-compliance/?utm_source=openai,https://www.scribd.com/document/457681671/ASEAN-GUIDELINE-ON-STABILITY-STUDY-OF-DRUG-PRODUCT-docx?utm_source=openai"
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Brunei,PARTIAL,"While specific regulations for bracketing and matrixing designs in Brunei are not publicly available, the country adheres to the ASEAN Stability Guideline which allows for their use under certain conditions.",https://www.scribd.com/document/237266472/Asean-Stability-Guideline-5th-Draft?utm_source=openai
Requires halal certification for pharmaceutical products.,Brunei,YES,"Brunei requires halal certification for pharmaceutical products, as established by guidelines from the Ministry of Religious Affairs which ensure compliance with Islamic law.","https://mofe.gov.bn/SitePages/HALAL%20STANDARD.aspx?utm_source=openai,https://halalfocus.net/brunei-first-to-establish-halal-pharma-guidelines/?utm_source=openai,https://simporpharma.com/contents/about_us_profile_story.html?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Brunei,NO,"Brunei does not mandate the use of a 'red dot' symbol on prescription-only pharmaceutical products, focusing instead on comprehensive labeling requirements for prescription drugs.",https://pt.scribd.com/presentation/414983438/Bfad-Guidelines-on-Labeling-of-Drug-Products?utm_source=openai
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Brunei,NO,"Brunei's average pharmaceutical product approval timeline exceeds six months, specifically ranging from approximately 8.5 to 14 months under standard procedures, without a consistent six-month target for approvals.","https://moh.gov.bn/SitePages/Registration%20Medical%20Product.aspx?utm_source=openai,https://pmc.ncbi.nlm.nih.gov/articles/PMC10664654/?utm_source=openai"
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Brunei,NO,"Brunei does not impose hospital-only distribution restrictions for certain classes of antimicrobial pharmaceutical products; instead, all antimicrobials are regulated as prescription-only medicines, allowing them to be prescribed by licensed practitioners without specific hospital-only limitations.","https://www.researchgate.net/publication/342330967_University_Students%27_Antibiotic_Use_and_Knowledge_of_Antimicrobial_Resistance_What_Are_the_Common_Myths?utm_source=openai,https://moh.gov.bn/about-us/policies/?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Brunei,NO,Brunei has established a national AMR surveillance system but has not published specific AMR surveillance data related to pharmaceutical products as of August 2025.,"https://www.informea.org/en/content/legislation/antimicrobial-resistance-national-action-plan-2019-2023?utm_source=openai,https://pmc.ncbi.nlm.nih.gov/articles/PMC8315476/?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Thailand,YES,"Thailand accepts the ICH Common Technical Document (CTD) format for innovator pharmaceutical product registrations, allowing submissions in both ICH CTD and ASEAN ACTD formats according to the Thai FDA.","https://en.fda.moph.go.th/entrepreneurs-medicines/how-to-apply-for-drug-pproval-01/?utm_source=openai,https://docest.com/doc/384729/food-and-drug-administration-thailand-bureau-of-drug-control?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Thailand,YES,Thailand provides a fully digital online submission portal for pharmaceutical product marketing authorization applications through its Integrated Regulatory Information Management System (ThaiRIMS) and the Drug E-Submission Service Center (DESS).,"https://thairims.fda.moph.go.th/user/index.php?utm_source=openai,https://en.fda.moph.go.th/news/the-open-of-drug-e-submission-service-center-a-new-stage-of-the-thai-fda/?utm_source=openai,https://globalforum.diaglobal.org/issue/september-2022/digitalization-in-the-asean-pharmaceuticals-market/?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Thailand,YES,"Thailand legally requires the acceptance of Good Manufacturing Practice (GMP) certificates from other ASEAN Member States (AMS) as mandated by the ASEAN Sectoral Mutual Recognition Arrangement (MRA) signed on April 10, 2009.","https://cil.nus.edu.sg/databasecil/2009-asean-sectoral-mutual-recognition-agreement-on-good-manufacturing-practice-gmp-inspection-of-manufacturers-of-medicinal-products/?utm_source=openai,https://en.fda.moph.go.th/international-relation/category/cat-international-cooperation/?utm_source=openai,https://globalforum.diaglobal.org/issue/march-2021/harmonization-of-gmp-inspection-and-benefits-to-asean-economic-community/?utm_source=openai"
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Thailand,NO,"Thailand does not permit stability data submission at 25°C/60% RH for pharmaceutical products, as it does not adhere to the ASEAN Stability Guidelines which specify 30°C ± 2°C with 75% RH ± 5% for long-term stability testing.",https://www.stabilitystudies.in/stability-studies-key-regulatory-guidelines-for-global-compliance/?utm_source=openai
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Thailand,YES,"Thailand permits the use of bracketing and matrixing study designs in pharmaceutical stability testing, aligning with ICH guidelines and regional ASEAN standards.","https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai,https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai"
Requires halal certification for pharmaceutical products.,Thailand,NO,"Thailand does not require halal certification for pharmaceutical products, although it can benefit manufacturers targeting the Muslim market.","https://www.halal.or.th/office/certificate_province/document/cert/20202/en?utm_source=openai,https://www.halalstandard.or.th/en/about-us?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Thailand,YES,Thailand mandates the use of a red circle with a black border and letter 'K' to indicate hard drugs that require a doctor's prescription.,https://www.herminahospitals.com/en/news-and-events/kenali-simbol-kode-warna-pada-obat-rs-hermina-pasuruan.html?utm_source=openai
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Thailand,NO,"Thailand does not consistently target an average MA approval timeline of six months or less for all pharmaceutical products, as timelines vary significantly depending on product type and registration pathway, with new chemical entities often taking 12 to 18 months and simplified pathways for generics requiring 6 to 12 months.",https://omcmedical.com/thai-food-and-drug-administration-tfda-drug-approval-processes/?utm_source=openai
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Thailand,NO,"Thailand has reclassified certain antibiotics as prescription-only, but there is no evidence of hospital-only distribution restrictions for these antimicrobial products.","https://pmc.ncbi.nlm.nih.gov/articles/PMC8381094/?utm_source=openai,https://pubmed.ncbi.nlm.nih.gov/29403113/?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Thailand,PARTIAL,Thailand publishes some antimicrobial resistance (AMR) surveillance data but faces challenges in full national coverage and integration across sectors.,"https://pmc.ncbi.nlm.nih.gov/articles/PMC5537745/?utm_source=openai,https://pmc.ncbi.nlm.nih.gov/articles/PMC8381094/?utm_source=openai,https://www.ihppthaigov.net/research/antimicrobial-resistance?utm_source=openai,https://pmac2023.com/specialEvent/4/details?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Myanmar,NO,"Myanmar does not accept the ICH CTD format for innovator pharmaceutical product registrations, requiring instead the ASEAN Common Technical Dossier (ACTD) format.","https://www.rginsight.com/registration-of-drug-product-in-myanmar-2025?utm_source=openai,https://www.pharmatutor.org/articles/registration-dossier-pharmaceuticals?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Myanmar,YES,"Myanmar has established a fully digital online submission portal for pharmaceutical product marketing authorization applications through the Department of Food and Drug Administration, enabling electronic submissions and payments for renewals starting January 1, 2024.","https://esubmission.fda.gov.mm/,https://www.gnlm.com.mm/fda-myanmar-starts-using-e-submission-with-digital-payment-for-registration-renewals/?utm_source=openai,https://www.myanmartradeportal.gov.mm/legal/540?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Myanmar,YES,"Myanmar is legally required to accept GMP certificates and inspection reports from other ASEAN Member States as per the ASEAN Sectoral Mutual Recognition Arrangement (MRA) for Good Manufacturing Practice, signed in 2009.",https://globalforum.diaglobal.org/issue/march-2021/harmonization-of-gmp-inspection-and-benefits-to-asean-economic-community/?utm_source=openai
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Myanmar,NO,"Myanmar does not permit stability data submission for pharmaceutical products at 25°C/60% RH, as the regulatory requirements stipulate long-term stability testing at 30°C/75% RH.","https://www.scribd.com/document/382268703/StabilityTable2-pdf?utm_source=openai,https://www.stabilitystudies.in/stability-studies-key-regulatory-guidelines-for-global-compliance/?utm_source=openai,https://arexcell.com/MMC_GMP_Wiki/index.php/WHO_TRS_1010_Annex_10?utm_source=openai"
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Myanmar,YES,"Myanmar permits the use of bracketing and matrixing study designs in pharmaceutical product stability testing, as these methodologies are recognized under the ASEAN guidelines, which align with ICH standards and require scientific justification.","https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai,https://pharmainterview.com/ich-q1d-guidelines-for-stability-testing-of-pharmaceutical-products/?utm_source=openai,https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai"
Requires halal certification for pharmaceutical products.,Myanmar,NO,"In Myanmar, halal certification for pharmaceutical products is not a mandatory requirement imposed by the government, although it can enhance market appeal and consumer trust among the Muslim population.","https://www.halaltimes.com/myanmars-halal-certification-dilemma-a-call-for-innovation-and-sustainability/?utm_source=openai,https://certease.com/halal-certification-in-myanmar/?utm_source=openai,https://cert-ease.com/halal-certification-in-myanmar/?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Myanmar,NO,"Myanmar does not specifically mandate the use of a 'red dot' symbol on prescription-only pharmaceutical products according to the National Drug Law enacted in 1992, which does not mention any symbols for labeling prescription drugs.","https://www.wipo.int/wipolex/en/legislation/details/6452?utm_source=openai,https://mandiradistra.com/en/health-tips/this-is-the-kind-of-symbol-for-drugs-there-is-a-logo-on-hard-drugs/?utm_source=openai,https://www.burmalibrary.org/sites/burmalibrary.org/files/obl/docs/Drug_Law_of_1992.html?utm_source=openai"
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Myanmar,NO,"Myanmar does not target an average marketing authorization approval timeline of six months or less, as the timelines for generic drugs range from 6 to 12 months and for new chemical entities, they can extend to 18 to 24 months.","https://credevo.com/articles/2021/01/25/myanmar-generic-drug-registration-process/?utm_source=openai,https://doczz.net/doc/8519955/southeast-asia-regulatory-landscape--part-2-?utm_source=openai,https://www.researchgate.net/publication/369416351_A_Study_of_Pharmaceutical_Product_Registration_Process_in_Myanmar_-A_First_Step_Towards_Developing_A_Product-Mix?utm_source=openai"
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Myanmar,NO,"Myanmar does not impose hospital-only distribution restrictions for certain classes of antimicrobial pharmaceutical products, which are available over the counter in both public and private sectors, contributing to concerns about resistance.","https://www.mdpi.com/2414-6366/6/2/70?utm_source=openai,https://www.wma.net/wmj_2023_04_final2/?utm_source=openai,https://pmc.ncbi.nlm.nih.gov/articles/PMC8167548/?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Myanmar,NO,Myanmar does not currently publish national AMR surveillance data related to pharmaceutical products due to challenges in implementing a centralized system and a lack of comprehensive data accessibility.,"https://www.informea.org/en/content/legislation/myanmar-national-action-plan-containment-antimicrobial-resistance-2017-2022?utm_source=openai,https://pmc.ncbi.nlm.nih.gov/articles/PMC8315476/?utm_source=openai,https://pubmed.ncbi.nlm.nih.gov/34070228/?utm_source=openai,https://pmc.ncbi.nlm.nih.gov/articles/PMC7568216/?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Philippines,YES,"The Philippines accepts the ICH CTD format for innovator pharmaceutical product registrations as per the Department of Health's Administrative Order No. 2013-0021, aligning with ASEAN harmonization while requiring compliance with specific regional standards for certain CTD sections.","https://www.global-regulation.com/law/philippines/471984/doh-administrative-order-no.-2013-0021.html?utm_source=openai,https://www.scribd.com/document/430375236/Drug-Approval-System-of-the-Philippines-pdf?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Philippines,YES,"The Philippines provides a fully digital online submission portal for pharmaceutical product marketing authorization applications through the FDA e-Portal System, which allows for digital submissions, pre-assessment, integrated payments, and application tracking.","https://www.pharmatomarket.com/philippines-fda-starts-pilot-implementation-of-eservices-portal-system-for-drug-products/?utm_source=openai,https://www.tripleiconsulting.com/how-register-huhs-products-with-fda-philippines/?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Philippines,YES,"The Philippines is legally required to accept certificates of Good Manufacturing Practice (cGMP) from other ASEAN Member States as it is a signatory to the ASEAN Sectoral Mutual Recognition Arrangement on GMP, which mandates such acceptance.","https://cil.nus.edu.sg/databasecil/2009-asean-sectoral-mutual-recognition-agreement-on-good-manufacturing-practice-gmp-inspection-of-manufacturers-of-medicinal-products/?utm_source=openai,https://www.npra.gov.my/index.php/en/industry-news-announcements/more-recent-updates/225-english/1527062-philippines-fda-included-in-list-of-asean-inspection-services.html?utm_source=openai,https://globalforum.diaglobal.org/issue/march-2021/harmonization-of-gmp-inspection-and-benefits-to-asean-economic-community/?utm_source=openai"
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Philippines,YES,"The Philippines permits the submission of stability data for pharmaceutical products stored at 25°C/60% RH, supported by long-term and accelerated stability studies as per ASEAN guidelines.",https://www.scribd.com/document/457681671/ASEAN-GUIDELINE-ON-STABILITY-STUDY-OF-DRUG-PRODUCT-docx?utm_source=openai
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Philippines,YES,"The Philippines allows the use of bracketing and matrixing in pharmaceutical product stability testing, adhering to ASEAN and ICH guidelines, with specific conditions and justifications required for certain complex drug delivery systems.","https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai,https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai"
Requires halal certification for pharmaceutical products.,Philippines,NO,"In the Philippines, halal certification is not mandatory for pharmaceutical products, although it can enhance market access and consumer trust, particularly in Muslim-majority regions.","https://en.wikipedia.org/wiki/Halal_certification_in_the_Philippines?utm_source=openai,https://www.hdiphilippineshalal.com/?utm_source=openai,https://salaamgateway.com/story/philippines-pharma-to-enter-halal-market?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Philippines,NO,"The Philippines does not specifically mandate the use of a 'red dot' symbol on prescription-only pharmaceutical products as indicated by Republic Act No. 5921 and FDA guidelines, which focus instead on other labeling requirements.","https://elibrary.judiciary.gov.ph/thebookshelf/showdocs/2/18576?utm_source=openai,https://fr.scribd.com/document/430375236/Drug-Approval-System-of-the-Philippines-pdf?utm_source=openai"
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Philippines,NO,"The standard processing time for initial applications of new pharmaceutical products in the Philippines is currently set at a maximum of 254 calendar days, which exceeds the six-month target for marketing authorization.","https://www.scribd.com/document/430375236/Drug-Approval-System-of-the-Philippines-pdf?utm_source=openai,https://pco.gov.ph/news_releases/fda-to-shorten-review-approval-process-of-generic-drugs-from-120-days-to-45-days/?utm_source=openai,https://trial.medpath.com/news/966b7b1612d94ee3/fda-to-slash-drug-approval-times-by-half-with-new-streamlined-procedures?utm_source=openai"
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Philippines,YES,"The Philippines imposes hospital-only distribution restrictions for certain classes of antimicrobial pharmaceutical products, requiring that hospitals have accredited laboratories to utilize these drugs, as mandated by DOH Administrative Order No. 2016-0034 and PhilHealth Circular No. 2018-0009.",https://legisph.com/statute/philhealth-circular-no-2018-0009?utm_source=openai
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Philippines,YES,"The Philippines publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products through the Antimicrobial Resistance Surveillance Program (ARSP), which has been operational since 1988 and releases annual reports that are publicly accessible.","https://arsp.com.ph/arsp-2022-annual-report-data-summary-is-now-available-for-download/?utm_source=openai,https://www.wma.net/news-post/24685/amr-bulletin-4-0/?utm_source=openai,https://www.who.int/westernpacific/health-topics/antimicrobial-resistance/wpracss?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Cambodia,NO,"Cambodia does not accept the ICH Common Technical Document (CTD) format for innovator pharmaceutical product registrations, as it adheres to the ASEAN Common Technical Dossier (ACTD) format instead.","https://pubmed.ncbi.nlm.nih.gov/32008246/?utm_source=openai,https://www.pharmatutor.org/articles/registration-dossier-pharmaceuticals?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Cambodia,YES,"Cambodia provides a fully digital online submission portal for pharmaceutical product marketing authorization applications through the Cambodia Pharmaceutical Online Registration System (CamPORS), launched in 2019 by the Ministry of Health.","https://www.eurocham-advocacy-compass.com/online-pharmaceutical-registration-platform-ref6072/?utm_source=openai,https://nhqconlineregistration.nhqc.org.kh/?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Cambodia,YES,"Cambodia legally requires acceptance of another ASEAN Member State's Certificate of Good Manufacturing Practice (cGMP) due to the ASEAN Sectoral Mutual Recognition Arrangement on GMP signed by all ASEAN member states on April 10, 2009.","https://cil.nus.edu.sg/databasecil/2009-asean-sectoral-mutual-recognition-agreement-on-good-manufacturing-practice-gmp-inspection-of-manufacturers-of-medicinal-products/?utm_source=openai,https://globalforum.diaglobal.org/issue/march-2021/harmonization-of-gmp-inspection-and-benefits-to-asean-economic-community/?utm_source=openai,https://www.trade.gov/healthcare-resource-guide-cambodia?utm_source=openai"
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Cambodia,NO,"In Cambodia, the ASEAN Stability Guidelines dictate that long-term stability testing must occur at conditions of 30°C ± 2°C with 75% relative humidity, implying that stability studies at 25°C/60% RH are not aligned with the guidelines and are insufficient for regulatory submissions.",https://www.researchgate.net/publication/284463697_Stability_testing_of_pharmaceutical_products_in_a_global_environment?utm_source=openai
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Cambodia,YES,"Cambodia allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing, in accordance with ASEAN and ICH guidelines that endorse these methods.","https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai,https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai"
Requires halal certification for pharmaceutical products.,Cambodia,NO,"Obtaining halal certification for pharmaceutical products in Cambodia is not mandatory, although it can enhance marketability and consumer trust.","https://www.ccfdg.gov.kh/en/about-ccf/department-of-halal/?utm_source=openai,https://www.ccfdg.gov.kh/en/commission-committee/new-title-3/?utm_source=openai,https://cert-ease.com/halal-certification-in-cambodia/?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Cambodia,NO,"Cambodia does not specifically mandate the use of a 'red dot' symbol on prescription-only pharmaceutical products, as indicated by the absence of such a requirement in their labeling regulations.","https://cambodiantr.gov.kh/commodity/impregnated-or-coated-with-pharmaceutical-substances/?utm_source=openai,https://www.scribd.com/document/822590612/labelling-of-allopathy?utm_source=openai,https://mandiradistra.com/en/health-tips/this-is-the-kind-of-symbol-for-drugs-there-is-a-logo-on-hard-drugs/?utm_source=openai"
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Cambodia,NO,"Cambodia does not target an average marketing authorization approval period of six months or less for pharmaceutical products, as the approval process for generic drugs typically takes between 6 to 12 months.",https://credevo.com/articles/2021/03/15/generic-drug-registration-process-in-cambodia/?utm_source=openai
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Cambodia,PARTIAL,"Cambodia has restrictions requiring prescriptions for antibiotics, but enforcement is hindered by informal sellers who distribute these medications without prescriptions, especially in rural areas.","https://www.phnompenhpost.com/national/who-misuse-of-antibiotics-costing-region-lives-billions-of-dollars?utm_source=openai,https://pmc.ncbi.nlm.nih.gov/articles/PMC6768357/?utm_source=openai,https://www.who.int/cambodia/news/detail/23-12-2019-cambodia-launched-multi-sectoral-action-plan-for-guiding-national-control-of-antimicrobial-resistance?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Cambodia,YES,"Cambodia publishes national antimicrobial resistance (AMR) surveillance data through a laboratory-based system established by the Ministry of Health, which includes reports accessible via the Cambodian CDC's dedicated webpage and a Multi-Sectoral Action Plan emphasizing surveillance.","https://www.ijidonline.com/article/S1201-9712%2820%2930882-1/fulltext?utm_source=openai,https://cjph.niph.org.kh/index.php/cjph/article/view/442?utm_source=openai,https://www.who.int/cambodia/news/detail/23-12-2019-cambodia-launched-multi-sectoral-action-plan-for-guiding-national-control-of-antimicrobial-resistance?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Singapore,YES,"Singapore accepts the ICH Common Technical Document (CTD) format for innovator pharmaceutical product registrations, as required by the Health Sciences Authority (HSA), which also plans to transition to electronic submissions with the eCTD system.","https://www.hsa.gov.sg/ctgtp/registration/overview/registration-process?utm_source=openai,https://www.extedo.com/blog/singapores-transition-to-ectd?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Singapore,YES,Singapore provides a fully digital online submission portal through the HSA's Pharmaceutical Regulatory and Information System (PRISM) and the EasiShare platform for pharmaceutical marketing authorization applications.,"https://www.pacificbridgemedical.com/uncategorized/singapore-drug-registration-a-comprehensive-guide/?utm_source=openai,https://insightplus.bakermckenzie.com/bm/healthcare-life-sciences/singapore-regulatory-updates-for-therapeutic-product-registration-august-2024?utm_source=openai,https://www.globalcompliancenews.com/2023/06/01/https-insightplus-bakermckenzie-com-bm-healthcare-life-sciences-singapore-health-sciences-authority-holds-industry-consultation-on-electronic-common-technical-document-implementation_05292023/?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Singapore,NO,"As of August 2025, Singapore does not legally require the acceptance of Certificates of Good Manufacturing Practice (cGMP) from other ASEAN Member States for pharmaceutical manufacturers, as per the regulations set by the Health Sciences Authority (HSA).",https://www.hsa.gov.sg/
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Singapore,NO,"Singapore's regulatory guidelines emphasize stability testing at higher temperatures and humidity levels, making submissions for data at 25°C/60% RH not compliant with local requirements (source: [xinfuda-group.com](https://www.xinfuda-group.com/news/stability-testing-of-new-drug-substances-and-products.html?utm_source=openai), [stabilitystudies.in](https://www.stabilitystudies.in/stability-studies-key-regulatory-guidelines-for-global-compliance/?utm_source=openai)).","https://www.xinfuda-group.com/news/stability-testing-of-new-drug-substances-and-products.html?utm_source=openai,https://www.stabilitystudies.in/stability-studies-key-regulatory-guidelines-for-global-compliance/?utm_source=openai"
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Singapore,YES,Singapore allows the use of bracketing and matrixing designs in pharmaceutical stability testing as long as they are scientifically justified and adhere to established guidelines such as those from ICH Q1D.,https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai
Requires halal certification for pharmaceutical products.,Singapore,PARTIAL,"Singapore's MUIS can certify pharmaceutical products, but it has primarily focused on consumables and there are reported restrictions against certifying non-consumables, which may include many pharmaceuticals.","https://www.muis.gov.sg/Halal/About?utm_source=openai,https://www.personalcaremagazine.com/story/15732/twenty-years-of-halal-manufacturing?utm_source=openai,https://www.prnewswire.com/ae/news-releases/pasture-announces-first-halal-certified-surgical-n95-masks-for-healthcare-and-public-use-856238029.html?utm_source=openai,https://www.theonlinecitizen.com/2021/01/28/halal-certification-conundrum-mccy-says-muis-wont-certify-non-consumables-but-reminds-companies-that-it-is-illegal-to-secure-foreign-halal-certification/?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Singapore,NO,"Singapore does not mandate the use of a 'red dot' symbol on prescription-only pharmaceutical products, as its medication classification is indicated by registration status rather than specific symbols.","https://en.wikipedia.org/wiki/Little_red_dot?utm_source=openai,https://www.pacificbridgemedical.com/ufaq/what-are-the-labeling-requirements-for-registered-drugs-in-singapore/?utm_source=openai,https://www.mims.com/SINGAPORE/Viewer/Html/PoisonCls.htm?utm_source=openai"
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Singapore,NO,"Singapore does not target an average marketing authorization approval timeline of six months or less; the full evaluation can take approximately 270 days, the abridged route around 180 days, and even the expedited verification route takes about 60 days, which exceeds the six-month target.",https://www.pacificbridgemedical.com/uncategorized/singapore-drug-registration-a-comprehensive-guide/?utm_source=openai
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Singapore,PARTIAL,"Singapore does not have explicit 'hospital-only' distribution restrictions for certain classes of antimicrobial products, but regulatory measures effectively limit their availability primarily to hospital settings through prescription-only classifications and antimicrobial stewardship programs.","https://www.proquest.com/docview/2856762647?utm_source=openai,https://www.todayonline.com/commentary/getting-hospitals-cut-down-inappropriate-prescription-antibiotics?utm_source=openai,https://www.cda.gov.sg/professionals/antimicrobial-resistance/amrco-nsap?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Singapore,YES,"Singapore publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products through the biennial 'One Health Report on Antimicrobial Utilisation and Resistance', coordinated by various governmental agencies including the Ministry of Health and the Antimicrobial Resistance Coordinating Office (AMRCO).","https://www.cda.gov.sg/professionals/antimicrobial-resistance/amrco-nsap?utm_source=openai,https://www.moh.gov.sg/others/resources-and-statistics/one-health-report-on-antimicrobial-utilisation-and-resistance-2021?utm_source=openai"
Accepts the International Council for Harmonisation (ICH) Common Technical Document (CTD) format for innovator pharmaceutical product registrations.,Malaysia,YES,"Malaysia accepts the ICH CTD format for the registration of innovator pharmaceutical products, as stated by the National Pharmaceutical Regulatory Agency (NPRA).","https://npra.gov.my/index.php/my/product-registration-process-for-nce/step-1-pre-submission-of-application-preparation-for-nce.html?utm_source=openai,https://www.rginsight.com/registration-of-drug-product-in-malaysia-2025?utm_source=openai"
Provides a fully digital online submission portal for pharmaceutical product marketing authorization applications.,Malaysia,YES,Malaysia provides a fully digital online submission portal for pharmaceutical product marketing authorization applications through the QUEST3+ system managed by the National Pharmaceutical Regulatory Agency (NPRA).,"https://npra.gov.my/index.php/my/submission-main-page?utm_source=openai,https://practiceguides.chambers.com/practice-guides/life-sciences-2024/malaysia?utm_source=openai,https://www.pacificbridgemedical.com/uncategorized/drug-registration-in-malaysia/?utm_source=openai"
Legally requires acceptance of another ASEAN Member State’s (AMS) Certificate of Good Manufacturing Practice (cGMP) for pharmaceutical manufacturers.,Malaysia,YES,"Malaysia is legally required to accept Good Manufacturing Practice (GMP) certificates from other ASEAN Member States under the ASEAN Sectoral Mutual Recognition Arrangement (MRA) established in 2009, which mandates cooperation in regulatory standards.","https://cil.nus.edu.sg/databasecil/2009-asean-sectoral-mutual-recognition-agreement-on-good-manufacturing-practice-gmp-inspection-of-manufacturers-of-medicinal-products/?utm_source=openai,https://www.pharmagmp.in/malaysias-npra-gmp-guidelines/?utm_source=openai,https://globalforum.diaglobal.org/issue/march-2021/harmonization-of-gmp-inspection-and-benefits-to-asean-economic-community/?utm_source=openai"
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.,Malaysia,PARTIAL,"Malaysia allows submission of stability data at 25°C/60% RH if supported by scientifically justified accelerated stability studies conducted under those conditions, despite the primary guidelines specifying other conditions.","https://npra.gov.my/index.php/en/component/content/article/94-industries/prescription/1487-step-1-pre-submission-of-application-preparation?Itemid=437&utm_source=openai,https://www.scribd.com/document/457681671/ASEAN-GUIDELINE-ON-STABILITY-STUDY-OF-DRUG-PRODUCT-docx?utm_source=openai"
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.,Malaysia,YES,"Malaysia permits the use of bracketing and matrixing study designs in pharmaceutical product stability testing, aligning with the ASEAN Guideline on Stability Study which harmonizes with ICH standards.","https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline?utm_source=openai,https://paperzz.com/doc/9443062/asean-guideline-on-stability-study-of-drug?utm_source=openai"
Requires halal certification for pharmaceutical products.,Malaysia,NO,"Malaysia does not require halal certification for pharmaceutical products, but it is highly encouraged for products intended for export to Muslim-majority countries, as overseen by the Department of Islamic Development Malaysia (JAKIM).","https://halalpharmacore.com/malaysia-product-certification/?utm_source=openai,https://www.mida.gov.my/mida-news/malaysia-leads-global-halal-pharmaceutical-industry/?utm_source=openai,https://en.wikipedia.org/wiki/Hovid_%28company%29?utm_source=openai"
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.,Malaysia,NO,"Malaysia does not specifically mandate the use of a 'red dot' symbol on prescription-only pharmaceutical products, as the current regulations focus on clear labeling without such symbols.",https://www.myrxnote.com/2020/11/labelling-of-medicine.html?utm_source=openai
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.,Malaysia,NO,"Malaysia's NPRA targets are set at 245 working days for new chemical entities and biologics, with actual approval times exceeding these, such as a median of 399 calendar days observed in practice.","https://pharmacy.moh.gov.my/en/content/clients-charter.html?utm_source=openai,https://link.springer.com/article/10.1007/s43441-025-00846-3?utm_source=openai"
Imposes hospital-only distribution restrictions for certain classes of antimicrobial (AM) pharmaceutical products.,Malaysia,YES,"Malaysia imposes hospital-only distribution restrictions for certain classes of antimicrobial pharmaceutical products as part of its Antimicrobial Stewardship Programme, requiring prior approval before use to ensure appropriate prescribing and combat antimicrobial resistance.","https://pharmacy.moh.gov.my/en/documents/protocol-antimicrobial-stewardship-program-healthcare-facilities.html?utm_source=openai,https://pubmed.ncbi.nlm.nih.gov/27648056/?utm_source=openai"
Publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products.,Malaysia,YES,"Malaysia publishes national antimicrobial resistance (AMR) surveillance data related to pharmaceutical products through various programs, such as the National Surveillance on Antimicrobial Utilisation (NSAU) and the National Surveillance of Antibiotic Resistance (NSAR), which monitor utilization and resistance patterns across the country.","https://sites.google.com/moh.gov.my/nag/information/antimicrobial-utilisation-data?utm_source=openai,https://imr.moh.gov.my/en/corporate-info/organisation-chart/75-english-content/national-collaboration/1469-nsar-main?utm_source=openai,https://www.who.int/westernpacific/newsroom/feature-stories/item/who-supports-the-strengthening-of-malaysia-s-antimicrobial-resistance-surveillance-and-laboratory-capacities-in-hospital-settings?utm_source=openai"
